肝移植后的细菌感染:当前状况,预防和治疗
Jingjie Guo1,2,3, Ying Wang1,2,3, Jingmiao Ma1,2,3
1Organ Transplantation Clinical Medical Center of Xiamen University, Department of General Surgery, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Frontiers in cellular and infection microbiology
|December 11, 2025
概括
肝移植接受者面临细菌感染的高风险,特别是来自多药耐药生物的风险. 早期检测和联合疗法对于改善这些脆弱患者的治疗结果至关重要.
科学领域:
- 医学微生物学 医学微生物学
- 移植免疫学 移植免疫学
- 传染性疾病 传染性疾病
背景情况:
- 肝移植 (LT) 为末期肝病提供了一种拯救生命的治疗方法,其存活率很高.
- 细菌感染是LT后的重大并发症,影响了移植功能,生活质量,并导致死亡率.
- 由于免疫抑制和免疫反应复杂性,LT接受者对感染的易感性增加.
研究的目的:
- 审查肝移植后细菌感染的流行病学和原因.
- 探索用于LT后细菌感染的新型诊断和治疗策略.
- 为这些感染的临床预测和预防提供见解.
主要方法:
- 关于LT后感染的流行病学数据的文献综述.
- 分析常见的细菌病原体,包括多药耐药生物 (MDR).
- 评估新兴的诊断技术 (如数字滴滴PCR,SERS) 和治疗方法.
主要成果:
- 格拉姆阴性和格拉姆阳性细菌是常见的病原体;MDR感染是一个重大挑战.
- 新技术在早期检测耐药细菌和评估移植损伤方面表现出高度的灵敏度.
- 综合性外科手术期间的抗生素和非抗生素疗法在预防感染和改善预后方面表现有前途.
结论:
- 目前缺乏有效的,国际公认的LT后感染预警系统.
- 解决诸如抗生素诱导的失生症和过度依赖传统方法等问题至关重要.
- 需要进一步研究和实施先进的诊断和综合疗法,以对抗LT后的细菌感染.
相关概念视频
Kidney Transplant III: Nursing Management
289
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
289
Kidney Transplant II: Surgical Procedure
279
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
279
Endocarditis III: Medical Management
197
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
197
Pleural Effusion II: Symptoms and Management
609
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
609
Endocarditis IV: Nursing Management
297
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
297
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K

